Category: Viking Systems Inc.Syndicate content

ConMed closes tender offer for Viking Systems | Wall Street Beat

September 24, 2012 by MassDevice staff

ConMed closes its 27¢-per-share tender offer for medical imaging company Viking Systems, giving it about 84% of Viking as it looks to close its short-form merger. Wall Street Beat

ConMed (NSDQ:CNMD) said it's closed its 27¢-per-share tender offer for Viking Systems (OTC:VKNG), leaving it with about 84% of shares in the medical imaging maker.

ConMed lays out $23M for Viking Systems

August 14, 2012 by MassDevice staff

ConMed agrees to pay 27¢ per share, or $22.5 million, for Viking Systems and its 3D surgical imaging system.

Viking Systems

Varian and Siemens launch global radiosurgery deal | Wall Street Beat

April 26, 2012 by MassDevice staff

Varian and Siemens sign global radiosurgery collaboration deal; Bausch & Lomb eyes new devices; Keir Surgical signs an exclusive distribution with Viking Systems; Fluoptics lands in Cambridge, Mass.; NxStage CEO Burbank sheds 9.2k shares ; and Baxter finalizes buyout of Sigma International; plus, a Funding Roundup and analysts' ups and downs. Wall Street Beat

 Varian and Siemens sign global radiosurgery collaboration deal

BD to deal labware biz to Corning for $730M | Wall Street Beat

April 10, 2012 by MassDevice staff

Becton, Dickinson & Co. agrees to sell its BD Biosciences - Discovery Labware unit to Corning Inc. for $730 million; also, Cook launches new biotech arm; Delcath goes Dutch; Positron buys isotope maker; Viking Systems releases Q1 prelims; Premier inks breast-screening deal with NeoMatrix; plus, a Funding Roundup and analysts' ups and downs. Wall Street Beat

Becton Dickinson & Co. (NYSE:BDX) said it agreed to sell its BD Biosciences - Discovery Labware unit to Corning Inc. (NYSE:GLW) for about $730 million in cash.

Boston Scientific launches Pluromed's BackStop kidney stone treatment | Wall Street Beat

April 2, 2012 by MassDevice staff

Boston Scientific launches its BackStop kidney stone treatment, licensed from Pluromed, in the U.S. and certain international markets; also, Siemens lands 3rd year defense contract worth up to $1.9 billion; Bruker Corp. nabs all shares of SkyScan for an undisclosed amount; Viking expects 40% sales growth for Q1 2012; Smith & Nephew acquires LifeModeler for an undisclosed amount; Wound Care Innovations signs exclusive N.A. Wall Street Beat

Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.

Report: Covidien to acquire superDimension for $350M | Wall Street Beat

March 14, 2012 by MassDevice staff

Covidien is said to be close to inking a $350 million deal for pulmonary diagnostic tool maker superDimension; also, Medtronic files for senior note offering; pSivida inks 2nd evaluation deal for Durasert eye implant; Viking Systems expands China footprint; BioDirection licenses Nanosys nanowire patents; Cameron Health buyout points to med-tech M&A trend; Covidien, Kensey Nash announce dividends; GPOs: Novation, Premier ink new hospital bed, HIT and wound care products; plus, a Funding Roundup and analysts' ups and downs. Wall Street Beat

Covidien (NYSE:COV) is set to close a $350 million buyout of Israeli lung diagnosis firm superDimension by the end of the week, according to Israeli business journal Calcalist.

Founded in Tel Aviv by Pinchas Gilboa, Minneapolis-based superDimension, which employs about 120 people worldwide, also has offices in Dusseldorf, Germany.

Angeion narrows Q1 losses despite flat sales | Earnings Roundup

March 1, 2012 by MassDevice staff

Angeion makes up for sagging European sales by focusing on group purchasing organizations and service revenues in Q1; also, Natus Medical's earnings plunge; Mindray posts big boosts to top, bottom lines; iCad narrows quarterly losses; MiMedx sales soar in 2011; InSite's sales slide, losses widen; Exactech's bottom line shrinks; Viking boosts sales, widens losses; MedPro cuts losses; and Alphatec dives deeper into the red.

Angeion logo

Angeion Corp. (NSDQ:ANGN) narrowed its 1st-quarter losses despite flat sales for the 3 months ended Jan. 31.

Although dragged down by a tough European climate, focusing on group purchasing organization and service revenues kept the company's sales from sliding, the cardiorespiratory diagnostic systems maker said.